Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). Additionally we are shipping FANCD2 Kits (10) and and many more products for this protein.
Showing 10 out of 141 products:
Dog (Canine) Polyclonal FANCD2 Primary Antibody for FACS, ICC - ABIN151329
Bekker-Jensen, Lukas, Kitagawa, Melander, Kastan, Bartek, Lukas: Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. in The Journal of cell biology 2006
Show all 116 references for 151329
Dog (Canine) Polyclonal FANCD2 Primary Antibody for ICC, IF - ABIN250520
Garcia-Higuera, Taniguchi, Ganesan, Meyn, Timmers, Hejna, Grompe, DAndrea: Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. in Molecular cell 2001
Show all 15 references for 250520
Dog (Canine) Polyclonal FANCD2 Primary Antibody for IHC, IHC (p) - ABIN250521
Rothfuss, Grompe: Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. in Molecular and cellular biology 2003
Show all 15 references for 250521
Human Monoclonal FANCD2 Primary Antibody for ChIP, IP - ABIN151782
Nomura, Adachi, Koyama: Human Mus81 and FANCB independently contribute to repair of DNA damage during replication. in Genes to cells : devoted to molecular & cellular mechanisms 2007
Show all 10 references for 151782
Human Polyclonal FANCD2 Primary Antibody for WB - ABIN151945
Taniguchi, Garcia-Higuera, Xu, Andreassen, Gregory, Kim, Lane, Kastan, DAndrea: Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. in Cell 2002
Show all 2 references for 151945
FANCD2 acts independently of previous S phases to promote alignment and segregation of acentric DNA produced by double-strand breaks.
Fancd2 has a role in DNA repair.
study showed that FANCI (show FANCI Antibodies)-FANCD2 is required for replication-coupled DNA interstrand cross-link (ICL) repair in S phase; results show that multiple steps of the essential S-phase ICL repair mechanism fail when the Fanconi anemia (show PALB2 Antibodies) pathway is compromised
The Fanconi anemia protein (show FANCF Antibodies) FANCM (show FANCM Antibodies) is controlled by FANCD2 and the ATR (show ATR Antibodies)/ATM (show ATM Antibodies) pathways.
silkworm cells deficient for FA proteins FancD2 and FancM (show FANCM Antibodies) exhibit normal sensitivities to hydroxyurea (HU) and camptothecin (CPT (show DHDDS Antibodies))
It was shown that silkworm FancD2 is monoubiquitinated depending on FancI (show FANCI Antibodies) and FancL (show FANCL Antibodies), and stabilized on chromatin, following mitomycin C. Depletion of FancD2, FancI (show FANCI Antibodies) or FancL (show FANCL Antibodies) effected cell proliferation in the presence of mitomycin C.
these findings provide a previously unrecognized central player FANCD2-V2 and thus novel insights into human tumorigenesis, and indicate that V2/V1 can act as an effective biomarker in assisting the recognition of tumor malignance
The data demonstrate that FANCD2 protein is required to ensure efficient chromosome fragile sites (CFS) replication and provide mechanistic insight into how FANCD2 regulates CFS stability.
A breakdown in a BRCA/FANCD2/BRG1 (show SMARCA4 Antibodies)/SNF (show SNRPA Antibodies)-DeltaNP63-mediated DNA repair and differentiation maintenance process in mammary epithelial cells may contribute to sporadic breast cancer development.
High FANCD2 expression is associated with drug Resistance in Malignant Melanoma.
study demonstrates that Fanconi anemia (show PALB2 Antibodies) pathway component FANCD2 is recruited to HPV DNA, associates with members of the ATM (show ATM Antibodies) DNA repair pathway, and is essential for the maintenance of viral episomes in basal epithelial cells
in Alternative Lengthening of Telomeres cells, FANCD2 promotes intramolecular resolution of stalled replication forks in telomeric DNA while BLM facilitates their resection and subsequent involvement in the intermolecular exchanges that drive Alternative Lengthening of Telomeres.
A new role of FANCD2 in limiting constitutive replication stress in BRCA2 (show BRCA2 Antibodies)-deficient cells, thereby affecting cell survival and treatment responses.
Collectively, these findings indicate that FANCD2 plays a novel role in the negative regulation of ferroptosis. FANCD2 could represent an amenable target for the development of novel anticancer therapies aiming to reduce the side effects of ferroptosis inducers.
In both patient and knockout cell lines reduced localisation of BLM to ultra fine DNA bridges and FANCD2 at foci linking bridges are observed. Overall, loss of RMI2 produces a partially active BLM complex with mild features of Bloom syndrome.
FANCD2 may have a role in progression of hepatocellular carcinoma
loss of Fancd2 yields significant defects to fetal liver hematopoiesis, particularly the HSC (show FUT1 Antibodies) population, which mimics key phenotypes from adult Fancd2 KO bone marrow independently of aging-accrued DNA damage.
Data that suggest Usp1 (ubiquitin specific peptidase 1 (show USP1 Antibodies)) down-regulation by autocleavage is critical for Usp1 (show USP1 Antibodies) to exert role in DNA interstrand crosslink repair; Usp1 (show USP1 Antibodies) role is de-ubiquitination of Fancd2 and Pcna (proliferating cell nuclear antigen (show PCNA Antibodies)).
recruitment of Fan1 (show FAN1 Antibodies) by ubiquitinated-Fancd2 is dispensable for DNA interstrand cross-links repair
Results show that FANCD2 and ADH5 (show ADH5 Antibodies) protect hematopoietic stem cells, hepatocytes, and nephrons from endogenous DNA damage resulting from accumulation of endogenous formaldehyde.
Combined deficiency of Foxo3a (show FOXO3 Antibodies) and Fancc (show FANCC Antibodies) or Fancd2 not only impairs the self-renewal capacity but also markedly increases the apoptosis of neural stem and progenitor cells (NSPCs), leading to defective neurogenesis.
Data demonstrated that Fancd2 was required for nuclear retention of CA-FOXO3a (show FOXO3 Antibodies) and for maintaining hematopoietic repopulation of the HSCs.
CD25 (show IL2RA Antibodies)(+)Foxp3 (show FOXP3 Antibodies)(+) Tregs of Fanca (show FANCA Antibodies)(-/-) or Fancd2(-/-) mice were less efficient in suppressing the production of GVHD-associated inflammatory cytokines.
Fancd2-Ub activates the transcription of the tumor suppressor TAp63, thereby promoting cellular senescence and blocking skin tumorigenesis.
Studies indicate that in Fancd2-Knockout mice, the formation of sex-cords and intraovarian tubules lead to the formation of tumours with multiple phenotypes including luteomas, papillary cysts and malignant carcinomas.
the Fanconi anaemia DNA repair pathway counteracts acetaldehyde-induced genotoxicity in mice; Aldh2 (show ALDH2 Antibodies)(-/-)Fancd2(-/-) mice spontaneously develop acute leukaemia
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity\; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in two transcript variants encoding different isoforms.
Fanconi anemia, complementation group D2
, Fanconi anemia group D2 protein-like
, fanconi anemia protein FANCD2
, Fanconi anemia complementation group D2
, Fanconi anemia group D2 protein
, Fanconi anemia group D2 protein homolog
, Fanconi anemia D2 protein